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Background: A number of factors have been identified as influencing total knee arthroplasty outcomes, including
patient factors such as gender and medical comorbidity, technical factors such as alignment of the prosthesis, and
provider factors such as hospital and surgeon procedure volumes. Recently, strategies aimed at optimizing provider
factors have been proposed, including regionalization of total joint arthroplasty to higher volume centers, and
adoption of volume standards. To contribute to the discussions concerning the optimization of provider factors and
proposals to regionalize total knee arthroplasty practices, we undertook a systematic review to investigate the
association between surgeon volume and primary total knee arthroplasty outcomes.
Methods: We performed a systematic review examining the association between surgeon volume and primary
knee arthroplasty outcomes. To be included in the review, the study population had to include patients
undergoing primary total knee arthroplasty. Studies had to report on the association between surgeon volume and
primary total knee arthroplasty outcomes, including perioperative mortality and morbidity, patient-reported
outcomes, or total knee arthroplasty implant survivorship. There were no restrictions placed on study design or
language.
Results: Studies were variable in defining surgeon volume (‘low’: <3 to <52 total knee arthroplasty per year; ‘high’:
>5 to >70 total knee arthroplasty per year). Mortality rate, survivorship and thromboembolic events were not found
to be associated with surgeon volume. We found a significant association between low surgeon volume and
higher rate of infection (0.26% - 2.8% higher), procedure time (165 min versus 135 min), longer length of stay
(0.4 - 2.13 days longer), transfusion rate (13% versus 4%), and worse patient reported outcomes.
Conclusions: Findings suggest a trend towards better outcomes for higher volume surgeons, but results must be
interpreted with caution.
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Primary total knee arthroplasty (TKA) is recognized
as an effective treatment for alleviating the pain and
disability associated with end stage knee osteoarthritis
[1,2]. Despite the widespread success of primary
TKA, a significant minority of patients (ranging from
10-20%) continue to experience complications and re-
port poor outcomes following this procedure [2,3]. The* Correspondence: rick.lau3@gmail.com
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reproduction in any medium, provided the orimplications are significant considering that the total
number of primary TKA procedures is expected to in-
crease by over 600% in the United States alone, to nearly
3.5 million procedures over the next 20 years [4].
A number of factors have been identified as influen-
cing TKA outcomes, including patient factors such as
gender and medical comorbidity [5,6], technical factors
such as alignment of the prosthesis [7], and provider factors
such as hospital and surgeon procedure volumes [8-10].
Recently, strategies aimed at optimizing provider factors
have been proposed, including regionalization of total. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of volume standards [8,10,11].
Higher hospital procedure volumes have been asso-
ciated with improved outcomes across a variety of car-
diac, vascular and oncologic surgeries [12-14]. Several
studies have examined the influence of hospital volume
on TKA outcomes as well [10,15-17]. Higher hospital
volumes have been shown to be negatively associated
with mortality rates and positively associated with im-
plant survivorship following TKA [18]. However, the as-
sociation between surgeon volume and TKA outcomes
is unclear. Over the past two decades a number of stu-
dies have examined the influence of surgeon volume on
various TKA outcomes. However, there has not been a
systematic review which has focused exclusively on sur-
geon volume and primary TKA outcomes. To contribute
to the discussions concerning the optimization of pro-
vider factors and proposals to regionalize TKA practices,
we undertook a systematic review to investigate the as-




To be included in the review, the study population had
to include patients undergoing primary TKA. Eligible
studies had to compare primary TKA outcomes between
low volume surgeons and high volume surgeons. Pri-
mary TKA outcomes including perioperative mortality
and morbidity, patient-reported outcomes, or TKA im-
plant survivorship were examined. Relevant papers were
reviewed using the Preferred Reporting Items for Sys-
tematic reviews and Meta Analyses (PRISMA) statement
as a guideline [19].
Information sources and study selection
We searched the Pubmed, OVID MEDLINE (1966 to
2011), and EMBASE (1974-2011) databases in October
2012 using the following search criteria: (knee arthro-
plasty OR knee replacement) AND (surgeon volume OR
surgeon experience). No restrictions were placed on
publication date, study design or language. Following
these initial searches, we performed a second electronic
search using the following terms: arthroplasty and vo-
lume, joint replacement and volume to further the
breadth of our search. Two authors screened all titles
and abstracts retrieved from this search (RLL, RG). Full-
length articles were retrieved for all articles that were
considered either potentially relevant or where there was
uncertainty as to the relevance. Additionally, the bibliog-
raphies of these full-length articles were reviewed and
full length articles retrieved for those references deemed
potentially relevant or of uncertain relevance. Full-length
articles were reviewed by two reviewers (RLL,RG) anddata was independently extracted. When manuscripts
included data on TKA and total hip arthroplasty (THA),
or primary TKA and revision TKA, they were excluded
unless the primary TKA data were reported separately.
Similarly, when manuscripts included data on hospital
and surgeon volume they were excluded unless the sur-
geon volume data was reported separate from hospital
volume data.
Data extraction
The following study characteristics were documented:
study design, date, data source, sample size, character-
ization of surgeon volume, and examined primary TKA
outcome(s).
Quality appraisal of studies
The studies that were included in our review underwent
an appraisal of the quality of methodology as outlined by
the Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE) system [20].
Results
Study selection
We identified 144 abstracts using our initial electronic
search for screening. Secondary electronic searches iden-
tified 824 and 949 abstracts for screening. After title and
abstracts were screened, 18 met inclusion criteria and
the full-length articles were retrieved and reviewed
[8-10,18,21-34]. Hand searches of the bibliographies of
these 18 articles resulted in the inclusion of 13 more
articles [11,15-17,35-43], for a total of 31. Following
the full-length reviews, 20 articles were excluded. Six-
teen were excluded because they did not compare low
volume surgeons to high volume surgeons [11,15-
17,29,33,35-44], two studies were excluded because
TKA data was mixed with THA data [23,34], one study
was excluded because primary TKA data was reported
with revision TKA data [10], and one study was found
to be a review article and thus, not eligible for inclusion
[24]. Eleven studies met our inclusion/exclusion criteria




All included studies were non-randomized, comparative
(low vs. high surgeon volume) observational trials. Nine
of the 11 studies were retrospective, and 2 were pro-
spective (Table 1).
Sample size
Sample size (n) was recorded as number of patients.
One study did not report the actual number of TKA
procedures in their manuscript [28]. The remaining
Figure 1 Selection of articles for review.
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ple size varied from a minimum of 260 to a maximum
of 80 904 (Table 1).
Patient data source
The majority of studies were North American based.
Five studies were from the United States (US), 2 from
Canada, 1 from United Kingdom, 1 from Japan, 1 from
Taiwan, and 1 from the Netherlands.
The US studies made use of two databases to identify
the patient cohorts. Four of the 5 studies utilized the US
Medicare database [8,9,18,28], and one used the Health
Care Cost and Utilization Project Nationwide Inpatient
Sample (HCUP-NIS) database [21]. The Medicare data-
base contains claims data for services provided to bene-
ficiaries (ages ≥65 years and those with certain
disabilities), including demographic, diagnostic and pro-
cedural data. The HCUP-NIS database was developed to
help track and analyze trends in health care utilization,
cost, quality and utilization and is collected on an annual
basis from a nationwide sample of community hospitals
in the US [10]. It contains information on all patientadmissions at the participating hospitals with patient
specific demographic and hospital data, as well as dis-
charge information.
The Canadian studies utilized the Ontario Health
Insurance Plan (OHIP) and Canadian Institute for
Health Information (CIHI) databases [25,32]. OHIP is
a government-run health insurance plan. Its database
contains claims data for all physician billing (inclu-
ding patient, physician and hospital specific data) in
the province of Ontario, Canada’s most populous
province. The CIHI maintains a national database of
hospital admissions, and was used to supplement the
OHIP data in the Kreder et al. and Paterson et al.
studies [25,32].
The United Kingdom study utilized a local joint re-
placement database to identify patients, and used hos-
pital records to collect data [22]. The national joint
registry in United Kingdom was also used to collect
demographic and procedure related data.
The Japanese study was derived from a nation-wide
internet survey of orthopedic surgeons [27]. Surgeons
provided patient information to survey questions from














80904 Retrospective US 2000 Medicare MR (90d), MI, infection, pneumonia, PE
Katz et al
(2007)









53971 Retrospective US 1997-2004 Medicare 2, 5, 8 year implant survivorship
Ong et al
(2009)
NR Retrospective US 1997-2004 Medicare Procedure duration
Yasunaga et
al (2009)












67713 Retrospective US 2002 HCUP database LOS
Baker et al
(2011)
260 Retrospective UK 2006-2007 Local Database and National
Joint Registry
Transfusion rate
(MR Mortality rate, LOS Length of stay, HCUP Health Care Utilization Project, PE Pulmonary embolus, DVT Deep venous thrombosis, MI Myocardial infarction,
WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, OHIP Ontario Health Insurance Plan, CIHI Canadian Institute for Health Information,
NHI National Health Insurance, NR Not reported).
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into a database and results analyzed.
The Taiwanese study used the National Health Insu-
rance (NHI) database [26]. The NHI stores data on 99%
of the population in Taiwan, with patient specific clinical
and demographic data collected since 1995.
The Dutch study used the surveillance network for
nosocomial infections [Preventie Ziekenhuisinfecties
door Surveillance Network database (PREZIES)] [30].
This database was designed in 1996, and collects data
from participating hospitals on surgical site infections.
Defining surgeon volume
In classifying surgeon volume, 10 of the 11 studies used
the annual number of procedures performed by the sur-
geon [8,9,18,21,22,25,26,28,30,32], whereas one study
utilized the career life-time number of procedures [27].
Significant variability was noted across studies in the
manner in which surgeons were classified as high versus
low volume. Thresholds were primarily based on tertiles
or quartiles of the study-specific surgeon volume distri-
butions. Five studies chose to use quartiles, and for these
we labeled the surgeon volume categories as low,
medium, high and very high [8,18,21,25,28]. Four studies
chose to define surgeon volume based on tertiles; for
these, we used the low, medium and high volume ca-
tegories [26,27,30,32]. One study defined low volumesurgeons as <52 procedures per year [22]. One study
defined low volume surgeons as <6 procedures per year
[9]. Due to the variability in categorization of surgeon
volumes across studies, ‘low’ surgeon volumes ranged
from < 3 to < 52 procedures per year across studies, and
‘high’ surgeon volume ranged from > 5 to > 70 proce-
dures per year (Table 2).Examined outcomes
Across studies, a variety of perioperative outcomes were
reported (Table 1), including in-hospital mortality rate
(MR) (2 of 11 studies) [27,32], 90 day MR (3 of 11 stu-
dies) [8,25,32], pulmonary embolism (PE) (2 of 11 stu-
dies) [8,27], and deep venous thrombosis (DVT) (1 of 11
studies) [27]. Surgical site infections were reported in 5 of
11 studies [8,26,27,30,32]. Variable time frames were con-
sidered: in-hospital infections [26], 90-day post-operative
period [8], 12-month post-operative period [30], and 3-
year post-operative period [32]. One study did not specify
time point [27]. Two studies measured deep infections
[8,27], and 3 studies did not specify [26,30,32].
Postoperative medical complications were reported in
6 of 11 studies [8,22,25-27,32]. Medical complications
were defined differently in each study, and included
myocardial infarction [8,25,26,32], pneumonia [8,25-27],
cerebrovascular accident [25,32], anaesthetic complications
Table 2 Surgeon volume thresholds and outcomes of the studies




Low Medium High V. High
Kreder et al
(2003)
<14 14-42 >42 – LOS p <
0.05
11.5 vs 10.0 days NR
MR (in-hospital) NS 0.5% vs 0.3% NR
MR (90 day) NS 0.8% vs 0.4% 1.76 (0.8-3.8) (LV:HV)
Infection (3 yr) NS 2.1% vs 2.3% 0.88 (0.5-1.3)(LV:HV)
Revision (3 yr) NS 2.2% vs 1.9% 1.00 (0.6-1.7)(LV:HV)
Medical complication NS 9% vs 11% 0.98 (0.7-1.3)(LV:HV)
Katz et al (2004) 1-12 13-25 26-50 >50 Pneumonia p <
0.01#
1.68% vs 1.02% 0.72 (0.54-0.95) (HV:LV)#
Infection p <
0.01#
0.55% vs 0.29% 0.62 (0.37-1.06) (HV:LV)#
MI NS 0.8% vs 0.69% 0.90 (0.64-1.28)(HV:LV)
PE NS 0.76% vs 0.74% 1.06 (0.73-1.54)(HV:LV)
MR (90d) NS 0.67% vs 0.58% 0.97 (0.66-1.43)(HV:LV)




22.6% vs 8.4% 2.1 (1.1-4.2) (LV:HV)
flex to 90 degrees p <
0.05
NR 2.9 (1.6-5.5) (LV:HV)
full extension p <
0.05
NR 2.2 (1.1-4.4) (LV:HV)
Dissatisfied with TKA NS NR 1.4 (0.6-3.3)(LV:HV)
Muilwijk et al
(2007)
5 – 12 – Infection p <
0.05
4.9% vs 2.1% 0.43 (0.23-0.80) (HV:LV)
Manley et al
(2009)
1-12 13-25 26-50 >50 Early - mid term survivoship
(8 years)
NS NR 0.94 (0.78-1.15)(LV:HV)
Ong et al (2009) 1-12 13-25 26-50 >50 Procedure duration p <
0.05





Used surgeon career volume of TKR
as surgeon volume variable: <100,
100-499, >499
Medical complication NS 7.7% vs 13.5% 1.17 (0.66-2.07) (HV:LV)





2-35 36-50 51-70 >70 LOS p <
0.05
NR NR
MR NS 0.624% vs 0.547% 1.02 (0.63-1.67)(HV:LV)
Readmission for surgery
(1 yr)
NS 0.594% vs 0.403% 0.81 (0.41-1.62)(HV:LV)
Revision (1 yr) NS 1.279% vs 0.922% 0.75 (0.51-1.09)(HV:LV)
Medical Complication NS 4.217% vs 4.553% 0.90 (0.67-1.19)(HV:LV)
Wei et al (2010) 1-3 4-9 10-
463
– LOS p <
0.05
10.79 vs 8.66 days NR
Infection p <
0.05
0.99% vs 0.54% 2.31 (1.379-3.876) (LV:HV)
Styron et al
(2011)
1-17 18-35 36-66 >67 LOS p <
0.05
4.14 vs 3.74 days NR
Baker et al (2011) 1-52 >52 Transfusion rate p <
0.05
13% vs 4% NR
(LV Low volume, HV High or v. high volume, MR Mortality rate, LOS Length of stay, NS Not significant, NR Raw proportions not reported, PE Pulmonary embolus,
DVT Deep venous thrombosis, MI Myocardial infarction, mins Time in minutes, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, * - see
Table 3 for covariates adjusted for in adjusted odds ratios, # - significant for trend, 95% CI = 95% confidence intervals, HV:LV = odds ratio expressed as high
volume to low volume, LV:HV Odds ratio expressed as low volume to high volume, TKA Total knee arthroplasty).
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bleeding [26], and anemia [22].
Five studies examined length of stay [21,25-27,32] and
one study examined procedure length [28] (Table 1).
Three studies examined 1-year, 3-year- and 8-year im-
plant survivorship, respectively [18,25,32], and one study
examined patient-reported outcomes, including the
Western Ontario and McMaster Universities Osteoarth-
ritis Index (WOMAC), patient satisfaction, patient-
reported ability to flex 90 degrees, and patient-reported
ability to fully extend [9] (Table 1).
Nine of 11 studies reported data on the measured out-
comes using raw comparative proportions as well as
adjusted odds ratios (OR) from multivariate logistic re-
gression analyses adjusting for a variety of covariates. A
summary of the study-specific covariates are presented
in Table 3.Quality appraisal of studies
All 11 studies were observational studies and are consid-
ered low quality studies as per GRADE system guide-
lines. None of the studies warranted an upgrade to
moderate quality due to the relative small effect of sur-
geon volume on outcomes examined.Study results
Mortality rate (MR) (In hospital - 2 studies,
90 day - 3 studies)
None of the studies identified a statistically significant
relationship between surgeon volume and MR.Table 3 Confounding variables controlled for in multivariate
Study Covariates controlled
Kreder et al (2003) age, comorbidity, gender, diagnosis, hospital procedure
Katz et al (2004) age, gender, comorbidity, Medicaid eligibility, diagnosis,






age, gender, race, diagnosis, hospital procedure volume
Manley et al
(2009)
age, gender, race, diagnosis, hospital procedure volume
Ong et al (2009) age, gender, comorbidity, race, diagnosis, Medicare eligi
hospital size, hospital procedure volume
Yasunaga et al
(2009)
age, gender, BMI, diagnosis, comorbidity, hospital proce
Paterson et al
(2010)
age, gender, comorbidity, diagnosis, hospital teaching st
Wei et al (2010) age, gender, diagnosis, comorbidity, hospital ownership
Styron et al (2011) age, gender, race, comorbidity, income, insurance status
ownership, hospital size, hospital procedure volume
Baker et al (2011) age, surgeon volume, preoperative hemoglobin, gender
(ASA American Society of Anesthesiologists, BMI Body mass index, WOMAC WesternPulmonary embolism and deep venous thrombosis
(2 studies)
Among the 2 studies examining PE and/or DVT, neither
reported a statistically significant association with sur-
geon volume.
Surgical site infection (5 studies)
Three of the 5 studies found a statistically significant as-
sociation (p < 0.05) between low surgeon volume and in-
fection rates [8,26,30]. Wei et al found a higher in-
hospital infection rate among low volume (LV) surgeons
[0.99% (LV) vs. 0.54% high volume (HV) surgeon,
adjusted OR: 2.31 (CI: 1.379 - 3.876)] [26] and Muilwijk
et al found a lower infection rate 1 year post-TKA
among HV surgeons [2.1% (HV) vs 4.9% (LV), adjusted
OR: 0.43 (CI: 0.23-0.80)] [30]. Neither study specified
whether this was deep or superficial surgical site infec-
tion. Katz et al found decreased deep infections at 90
days post-TKA among HV surgeons [0.29% (HV) vs.
0.55% (LV), adjusted OR: 0.62 (CI: 0.37-1.06)], which
was statistically significant for trend (p = 0.006) [8]. Two
studies did not find a significant association between
surgeon volume and infection rate [27,32].
Medical complications (6 studies)
Katz et al (2004) found a statistically significant decrease
in pneumonia rates following TKA for HV surgeons
[1.02% (HV) vs. 1.68% (LV), adjusted OR 0.72 (CI 0.54 -
0.95)] [8]. Baker et al (2011) found a statistically signifi-
cant decrease in transfusion rate following TKA for HV
surgeons compared to LV surgeons (4% vs 13%). Theanalysis in each study
volume
hospital procedure volume
idity, preoperative patient reported outcome (WOMAC)
, hospital teaching status, hospital ownership, hospital region, income
, hospital teaching status, hospital ownership, hospital region, income
bility, hospital teaching status, hospital ownership, hospital location,
dure volume
atus, hospital procedure volume
, hospital region
, geographic region, hospital region, hospital teaching status, hospital
, type of anaesthetic, ASA, surgeon experience, indication
Ontario and McMaster Universities Osteoarthritis Index).
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cant association between surgeon volume and post-
operative medical complications [25-27,32] (Table 2).
Length of stay (5 studies)
Four studies reported a significant increase in LOS
among patients of LV surgeons [21,25,32,45]. Yasunaga
et al did not find a significant association between LOS
and surgeon volume [27]. Numerical data for LOS were
not uniformly reported across studies and are summar-
ized in Table 2.
Procedure length (one study)
Ong et al found a significant increase in TKA procedure
time for LV surgeons (165 min vs 135 min) [28].
Implant survivorship (3 studies)
Manley et al (2009) did not find a significant association
between 8-year implant survivorship and surgeon vo-
lume [18]. Similarly, Kreder et al (2003) and Paterson et
al (2010) did not find a significant association between
surgeon volume and 3-year and 1-year revision rate, re-
spectively [25,32] (Table 2).
Patient-reported outcomes (one study)
Patients of LV surgeons had significantly lower (i.e.
worse) WOMAC scores [76 (LV) vs. 83 (HV)], and were
more likely to have a WOMAC score of < 60 [22.6%
(LV) vs. 8.4% (HV), adjusted OR 2.1 (CI 1.1 - 4.2)], two
years post TKA [9]. In addition, patients of LV surgeons
were more likely to report an inability to flex the knee to
90 degrees (adjusted OR 2.9, CI 1.6 - 5.5), and more
likely to report an inability to achieve full extension at 2
years post operation (adjusted OR 2.2, CI 1.1 - 4.4) [9]
(Table 2).
Discussion
Understanding the relationship between provider vo-
lume and outcomes for TKA is critical to informing dis-
cussions concerning ‘centralization’ or ‘regionalization’
[24] and overall efforts to improve quality and outcomes
of care in TKA. The principle behind centralization or
regionalization is that improved patient outcomes can be
achieved by concentrating complex surgical procedures
in regional centers, or “centers of excellence”. Several
studies have demonstrated a relationship between higher
provider volumes and improved outcomes for surgical
procedures such as coronary artery bypass grafting, aor-
tic aneurysm repair, carotid endarterectomy, and com-
plex gastrointestinal surgeries [46]. Two principal
hypotheses have been put forward to explain these
observations: (1) physicians and hospitals develop more
effective skills as they treat more patients (‘practice
makes perfect’) and (2) physicians and hospitalsreporting better outcomes receive more referrals and
thus accrue larger volumes (‘selective referral’) [14,46]. If
these hypotheses are broadly applicable, our expectation
was that similar positive associations between higher
surgeon volume and improved patient outcomes would
be observed in TKA.
Our review of the limited literature in primary TKA
revealed significant variability across studies in the
categorization of surgeon procedure volumes. This va-
riability rendered comparisons of study findings challen-
ging, and highlighted a critical need for consistency in
future research. Despite these challenges, we report a
general trend of improved outcomes among ‘higher’ vo-
lume surgeons although we are careful to note that sta-
tistical significance was not achieved across all studies or
outcomes. After reviewing the available studies, we
would identify a high surgeon volume as > 50 TKA per
year. Three studies identified a statistically significant re-
lationship between low surgeon volume and higher in-
fection rates (0.26% - 2.8% higher). While the magnitude
of the reported differences in infection rates were rela-
tively small, when considered in the context of the
expected 3.5 million TKA procedures to be performed
over the next 20 years in the US alone, this may repre-
sent a significant outcome at a population level.
The majority of studies examining LOS found a statis-
tically significant increase in LOS for LV surgeons. Evi-
dence on process of care adherence (such as use of
antibiotic prophylaxis, DVT prophylaxis, beta-blocker
use in high risk patients) has demonstrated that adhe-
rence to evidence-based processes of care improves
quality of care and decreases LOS in total joint replace-
ment surgery [23]. Bozic et al found a weak negative cor-
relation between surgeon volume and number of missed
evidence based processes of care [23]. It is possible that
adherence to evidence based processes of care may ac-
count for some of the decreases in LOS for HV sur-
geons. Similarly, utilization of clinical care pathways for
patients undergoing total joint arthroplasty have also
demonstrated improved quality of care and shorter LOS
[47-49]. It is not known however, if LV surgeons are less
likely to utilize a clinical care pathway. Further study in
the relationship between surgeon volume, clinical care
pathways and process of care measures may be useful in
understanding why LV surgeons have longer LOS.
Early to midterm (up to 8 years) implant survivorship
did not appear to be influenced by surgeon volume
[18,25,32]. Whether similar findings hold over the
longer-term (i.e. >8 years) is unknown. Further long
term survivorship studies would be useful in under-
standing the relationship between surgeon volume and
implant survivorship.
In the one study which examined patient-reported out-
comes, Katz et al (2007) reported a positive association
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However, the lack of additional studies examining pa-
tient-reported outcomes precludes any general statement
concerning the influence of surgeon volume on these
outcomes. It also highlights an important need for fur-
ther work in this area to critically inform relevant policy
discussions and decisions concerning TKA.
Studies examining hospital volume and TKA out-
comes have demonstrated decreased mortality, infection
and pulmonary embolism [8,10,16,32,39]. Furthermore,
two studies have demonstrated decreased TKA survivor-
ship for low volume hospitals [18,32]. Given these find-
ings, hospital volume appears to have more impact on
outcome for TKA than surgeon volume, however the
quality and limitations of these studies prevents the de-
livery of definitive or ‘strong’ recommendations at this
point [20]. Further studies will be important in deter-
mining the relative importance of surgeon volume and
hospital volume to TKA outcome.
In 2002, Halm et al performed a review of the litera-
ture on volume-related outcomes in health care, and
included a wide variety of surgical procedures [14]. They
identified one study that examined the influence of hos-
pital volume on TKA outcomes. In 2007, Shervin et al
performed a review of orthopedic procedures, examining
the association between hospital and surgeon volume,
and outcomes [50]. In their review, they included 4 stu-
dies examining TKA outcomes and surgeon volume
which are also included in this review. Finally, 2 recent
reviews by Marlow et al and Critchely et al, examined
surgeon volume and outcomes in TKA procedures. Both
reviewed primary and revision knee arthroplasty proce-
dures [24,51]. Marlow et al included 3 studies that
examined surgeon volume and primary TKA outcomes
[24]. Critchley et al presented data on primary hip and
knee arthroplasty procedures together [51]. The present
review differs from and expands on the prior reviews in
that the present focus was on primary TKA outcomes
alone, and the association with surgeon volume. Further-
more, we included several recently published studies not
included in previous reviews.
Due to the nature of the literature from which this re-
view was derived, there are study limitations. Studies on
surgeon volume are primarily retrospective in nature
and based on national health care databases and surveys
which are limited in the number of variables collected.
Furthermore, different health care databases capture dif-
ferent patient groups making comparisons challenging.
Medicare data in the US contains data on patients over
65, which is different from other national health care
databases such as OHIP. As with all non-randomized
studies, there is potential for uncontrolled confounding
factors which can bias the results. Additionally, the stu-
dies reviewed were variable in methodology, withvariable thresholds for surgeon volume categorization.
Similarly, studies were highly variable in outcomes mea-
sured (i.e. superficial vs. deep infection), and timing of
measured outcomes (i.e. in-hospital vs. 90 day MR). The
variability across the key variable of surgeon volume pre-
cluded formal meta-analysis from being performed.
While our findings suggest a trend towards better out-
comes for higher volume surgeons, we do not believe
there is sufficient evidence to fully support initiatives to
concentrate procedures within specific regions or centres
on the basis of surgeon volume alone. All of the available
studies are of ‘low quality’ as per GRADE system, making
any clinical recommendations challenging. In addition, it
is unclear if this general trend of improved outcomes for
higher volume surgeons warrants regionalization to higher
volume surgeons. Studies examining the effect of
regionalization of TKA to high volume hospitals provide
some evidence that regionalization may not be the solu-
tion [35,52]. Evidence suggests that some patients would
refuse to have surgery in an unfamiliar setting, preferring
to attend a local health provider with lower procedure vol-
ume [35,52]. In the US, the poor, less educated, elderly, as
well as racial/ethnic minorities are more likely to undergo
TKA at low volume centers [11,36,38]. Regionalization of
TKA to high volume centres and surgeons may further
exacerbate existing disparities in the utilization of TKA
and restrict access to some patients who would otherwise
use a low volume provider for TKA, increasing the num-
ber of patients who decline or defer their elective TKA
surgery with resultant poorer health outcomes [2,11,53].
A regionalization program involving referral to high vo-
lume surgeons and hospitals might decrease the already
low rate of perioperative complications at the cost of in-
creasing arthritis related disability [11]. Evidence suggests
that having TKA in low volume hospitals costs more and
produces worse outcomes than having TKA in high vo-
lume centers, but having TKA in low volume centers is
still more cost effective than not having TKA at all [35].
While these studies were specific to examining the role of
hospital volume on cost effectiveness of TKA, it is possible
that the same may hold true for surgeon volume and
TKA. Further study into the cost effectiveness of
regionalization will be paramount before a universal refer-
ral program designed to shift patients to high volume sur-
geons becomes policy. Cost utilization and effectiveness
will be crucial as healthcare resources become more
scarce, with the principle of providing optimum patient
care in the most efficient manner the ultimate goal.
Conclusions
There is a general trend towards better outcomes for
higher volume surgeons, however it is unclear if this
trend warrants widespread adoption of regionalization
policies. The evidence that is available is of ‘low quality’
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available evidence is weak. Further study is needed be-
fore regionalization policies are adopted.
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